Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT  Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer by Yamamoto, T et al.
Accepted Manuscript
Changes in Regional Ventilation during Treatment and Dosimetric Advantages of CT
Ventilation Image-Guided Radiotherapy for Locally Advanced Lung Cancer
Tokihiro Yamamoto, Ph.D., Sven Kabus, Ph.D., Matthieu Bal, Ph.D., Karl Bzdusek,
Ph.D., Paul J. Keall, Ph.D., Cari Wright, B.S., Stanley H. Benedict, Ph.D., Megan E.
Daly, M.D.
PII: S0360-3016(18)30741-7
DOI: 10.1016/j.ijrobp.2018.04.063
Reference: ROB 24972
To appear in: International Journal of Radiation Oncology • Biology • Physics
Received Date: 9 December 2017
Please cite this article as: Yamamoto T, Kabus S, Bal M, Bzdusek K, Keall PJ, Wright C, Benedict
SH, Daly ME, Changes in Regional Ventilation during Treatment and Dosimetric Advantages of CT
Ventilation Image-Guided Radiotherapy for Locally Advanced Lung Cancer, International Journal of
Radiation Oncology • Biology • Physics (2018), doi: 10.1016/j.ijrobp.2018.04.063.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Changes in Regional Ventilation during Treatment and Dosimetric 
Advantages of CT Ventilation Image-Guided Radiotherapy for Locally 
Advanced Lung Cancer 
 
Tokihiro Yamamoto, Ph.D.,1 Sven Kabus, Ph.D.,2 Matthieu Bal, Ph.D.,3 Karl Bzdusek,4 5 
Ph.D., Paul J. Keall, Ph.D.,5 Cari Wright, B.S.,1 Stanley H. Benedict, Ph.D.,1 and Megan 
E. Daly, M.D.1 
 
1Department of Radiation Oncology, University of California Davis, Sacramento, 
California 10 
2Department of Digital Imaging, Philips Research, Hamburg, Germany 
3Philips Healthcare, Best, The Netherlands 
4Philips Healthcare, Fitchburg, WI 
5Radiation Physics Laboratory, Sydney Medical School, University of Sydney, New 
South Wales, Australia 15 
 
Reprint request to: Tokihiro Yamamoto, Ph.D., Department of Radiation Oncology, 
University of California Davis, 4501 X St., Sacramento, California 95817.  Tel: (916) 
734-0604; E-mail: toyamamoto@ucdavis.edu 
 20 
Short title: Ventilation image-guided adaptive radiotherapy 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
Funding: This study was supported in part by the American Cancer Society and the 
Dean of the UC Davis School of Medicine (ACS IRG-95-125-13) (T.Y. and M.E.D.) and 
National Institutes of Health/National Cancer Institute grant K12CA138464 (M.E.D.). 25 
 
Acknowledgment: Philips Radiation Oncology Systems loaned us a research version 
of the Pinnacle3 treatment planning system. 
 
Conflict of interest: Drs. Kabus, Bal and Bzdusek are employees of Philips.  Dr. Keall 30 
is an inventor of the issued patent, Method and system for using computed tomography 
to test pulmonary function (US 7668357). 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Abstract  
Purpose/Objective: Lung functional image-guided radiotherapy (RT) that avoids irradiating 
highly-functional regions has potential to reduce pulmonary toxicity following RT.  Tumor 
regression during RT is common, leading to recovery of lung function.  We hypothesized that 
computed tomography (CT) ventilation image-guided treatment planning reduces the functional 5 
lung dose compared to standard anatomical image-guided planning in two different scenarios 
with or without plan adaptation. 
Methods and Materials: CT scans were acquired before RT and during RT at two time points 
(16-20 Gy and 30-34 Gy) for 14 patients with locally advanced lung cancer.  Ventilation images 
were calculated by deformable image registration (DIR) of four-dimensional (4D) CT image 10 
datasets and image analysis.  We created four treatment plans at each time point for each 
patient: functional adapted, anatomical adapted, functional unadapted, and anatomical 
unadapted plans.  Adaptation was performed at two time points.  DIR was used for 
accumulating dose and calculating a composite of dose-weighted ventilation used to quantify 
the lung accumulated dose-function metrics.  The functional plans were compared with the 15 
anatomical plans for each scenario separately to investigate the hypothesis at a significance 
level of 0.05. 
Results: Tumor volume was significantly reduced by 20% after 16-20 Gy (p=0.02) and by 32% 
after 30-34 Gy (p<0.01) on average.  In both scenarios, the lung accumulated dose-function 
metrics were significantly lower in the functional plans than in the anatomical plans without 20 
compromising target volume coverage and adherence to constraints to critical structures.  For 
example, functional planning significantly reduced the functional mean lung dose by 5.0% 
(p<0.01) compared to anatomical planning in the adapted scenario, and by 3.6% (p=0.03) in the 
unadapted scenario. 
Conclusions: This study demonstrated significant reductions in the accumulated dose to the 25 
functional lung with CT ventilation image-guided planning compared to anatomical image-
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guided planning for patients showing tumor regression and changes in regional ventilation 
during RT. 
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Introduction  30 
Radiotherapy (RT) for lung cancer is limited by substantial pulmonary toxicity that diminishes 
quality of life [1-3], particularly for locally advanced disease.  Common toxicities include 
radiation pneumonitis (potentially fatal) that occurs in up to 30-40% of patients irradiated for 
locally advanced lung cancer [3,4], pulmonary fibrosis that occurs in about 8% [4,5], and lung 
function loss, e.g., 4-27% reduction in diffusing capacity of the lung for carbon monoxide (DLCO) 35 
[1,6].  Lung functional image-guided RT, which preferentially avoids irradiating highly-functional 
lung regions, has potential to reduce pulmonary toxicity, and thereby improve quality of life.  
Dosimetric significance of lung functional image-guided RT has been demonstrated by several 
investigators [7-11].  Recently, Faught et al. translated the reduction in the functional lung dose 
to an estimated reduction in the risk of severe pneumonitis by 5-8% on average for the 40 
population and as high as 52% for individual patients (clinically-used anatomical image-guided 
planning without adaptation versus functional image-guided planning without adaptation) [12].  
Other key evidence that supports functional image-guided RT includes improved toxicity 
prediction based on regional ventilation and perfusion [13,14], and dose-dependent reductions 
in regional ventilation and perfusion after RT [15,16]. 45 
 
Many lung cancer patients experience tumor shrinkage during a course of RT at a rate of 0.6-
2.4% per day (tumor volume) [17].  Several investigators have reported significant increases in 
regional ventilation and perfusion during a course of RT for lung cancer, and speculated that 
those changes might be attributed to re-opening of airways and vessels as a result of tumor 50 
shrinkage [18-20].  Yuan et al. reported significant reductions in ventilation and perfusion 
defects measured with single-photon emission computed tomography (SPECT) imaging after 45 
Gy compared to pre-RT images [19].  These findings suggest that functional image-guided 
unadapted plans might end up with little reduction in the accumulated dose to the functional 
lung, as dose is redistributed to regions that are poorly functional before RT but may become 55 
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functional during RT.  There have been no studies to quantify the dosimetric impact of changes 
in regional lung function during RT.  Also, adaptive RT strategies to account for such changes 
during RT [21-23] have not been investigated for functional image-guided RT. 
 
Several modalities exist for pulmonary ventilation imaging, including an emerging method based 60 
on four-dimensional (4D) computed tomography (CT) and image processing (henceforth 
referred to as CT ventilation imaging).  CT ventilation imaging has higher resolution, shorter 
exam time, lower cost, and greater availability compared to other modalities.  CT ventilation can 
often be considered ‘free’ information in RT, as 4D CT is in routine use for respiratory motion 
assessment in RT planning at many centers (approximately 70% of RT centers in the US [24]) 65 
and ventilation computation only involves image processing and analysis.  Therefore, CT 
ventilation imaging has great potential for widespread clinical implementation.  The accuracy 
and precision of CT ventilation imaging have been investigated extensively through animal 
studies [25-27] and human studies [27-37].  Reasonable correlations with pulmonary function 
tests (PFTs) [33,35] and ventilation images acquired with other methods [25,26,28,30,32-34,37] 70 
indicate the physiological significance of CT ventilation imaging.  For example, Brennan et al. 
found moderate to strong correlations (range: 0.63-0.72) between the CT ventilation metrics 
(e.g., coefficient of variation, the relative volume of lung with ≤20% ventilation) and PFT 
parameters (e.g., forced expiratory volume in 1 second) in a 98-patient study [35]. 
 75 
The purpose of this study was to quantify the dosimetric advantages of CT ventilation functional 
image-guided RT planning for locally advanced lung cancer in two different scenarios with or 
without plan adaptation.  We hypothesized that CT ventilation image-guided treatment planning 
reduces the functional lung dose compared to standard anatomical image-guided planning in 
both scenarios. 80 
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Methods and Materials 
Patients 
In an ongoing prospective clinical trial approved by the institutional review board (detail omitted 
for blind review) evaluating the feasibility of CT ventilation functional image-guided RT, 14 85 
patients with stage III non-small cell lung cancer (NSCLC) underwent protocol-defined, mid-RT 
4D CT scans as well as planning 3D CT scans at two time points (after 16-20 Gy and 30-34 Gy) 
in addition to pre-RT scans.  All patients were treated with functional image-guided plans 
without adaptation per protocol, and provided written informed consent prior to enrollment.  
Table 1 summarizes patient characteristics. 90 
 
Imaging 
All CT scans were acquired using a Brilliance Big Bore multislice CT scanner (Philips 
Healthcare, Andover, MA).  For 4D CT, the respiratory signal was acquired using a pneumatic 
belt and the following scanning parameters were used consistently: 120 kVp, 120 mA, and 2 95 
mm slice.  Although breathing guidance (e.g., audiovisual biofeedback) was not used in this 
study, we provided verbal instruction to patients to maintain regular breathing.  The B (standard) 
algorithm was used for image reconstruction.  The phase-based method was used for 4D CT 
sorting.  Patients were positioned using the same patient-specific immobilization devices 
throughout all CT scans to reduce variability in positioning. 100 
 
CT ventilation imaging 
CT ventilation imaging is based on (1) DIR of 4D CT image datasets and (2) quantitative image 
analysis for regional volume change as a surrogate for ventilation.  DIR was performed between 
the selected inhale 4D CT image data set (moving) to the peak-exhale image data set (fixed) to 105 
ensure consistency in the tidal volume between three different time points of 4D CT scans, i.e.,  
equivalent tidal volume (ETV) normalization [38].  Du et al. found significantly improved 
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reproducibility in ETV-normalized CT ventilation compared to peak-inhale/exhale CT ventilation, 
when tidal volume variations were greater than 150 cm3 [38].  In this study, the inhale phase 
was selected such that tidal volume variations were smaller than 150 cm3.  The tidal volume 110 
was determined by subtracting the volume of segmented lung in the peak-exhale image from 
that of a given inhale image.  DIR was performed using a volumetric elastic algorithm that 
minimizes both a similarity function (sum of squared difference between) and a regularization 
term (elastic regularization) [39].  The accuracy of this algorithm has been previously evaluated 
thoroughly [39-41] and shown to have sub-voxel accuracy on average [40].  The same level of 115 
accuracy was assumed in this study, and only visual inspection of subtraction images (fixed 
minus deformed moving) was performed to check for major errors.  No major errors were 
observed in this study, except for some local errors around 4D CT image artifacts (see the 
Discussion section).  Regional ventilation was quantified using the Hounsfield unit (HU)-based 
metric [42,43] scaled by a local CT density [32,33].  Ventilation values were converted into 120 
percentile values for intensity-modulated RT (IMRT) planning as well as data analysis in this 
study.  See Appendix eI for further details on CT ventilation imaging. 
 
Treatment planning and plan adaptation 
We created four IMRT plans at each time point for each patient: (1) functional image-guided 125 
planning with plan adaptation, (2) anatomical image-guided planning with adaptation, (3) 
functional image-guided planning without adaptation, and (4) anatomical image-guided planning 
without adaptation.  Contouring of the target volumes and critical structures was performed 
manually on the planning CT image at each time point.  The gross tumor volume (GTV), which 
was defined as the primary tumor and any regionally involved lymph nodes identified by the 130 
planning CT image at each time point, was contoured by the same thoracic radiation oncologist 
(detail omitted for blind review) for all cases.  The internal target volume (ITV) was defined as 
the envelope that encompassed the GTV plus a full range of motion of the primary tumor and 
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nodal target identified by 4D CT.  The clinical target volume (CTV) was determined by adding a 
margin of 5 mm to the ITV at each time point, assuming that the microscopic disease shrank 135 
synchronously with the GTV [21,22].  The planning target volume (PTV) was determined by 
adding an additional margin of 5 mm to the CTV.  Major critical structures contoured include the 
lungs, spinal cord, esophagus, and heart. 
 
All IMRT plans were created by the same dosimetrist (detail omitted for blind review) with 140 
coplanar or non-coplanar 6 MV photon beams on the planning CT image at each time point, i.e., 
pre-RT and mid-RT (16-20 Gy and 30-34 Gy).  The dose of 60 Gy was prescribed to 95% of the 
PTV.  To ensure consistency in target volume coverage between the paired plans in each 
scenario, all treatment plans (except for the mid-RT unadapted plans) were designed to meet 
the following dose specifications at each time point: (1) the minimum dose to the PTV must be 145 
≥90% of the prescription dose, and (2) the maximum dose to the PTV must be ≤115% of the 
prescription dose.  The isocenter was placed approximately in the target centroid position in the 
pre-RT planning CT image.  The same position relative to the triangulation setup marks was 
used to place the isocenter in the 16-20 Gy and 30-34 Gy planning CT images.  Functional 
plans were designed to preferentially avoid irradiating highly-functional lung regions and meet 150 
standard dose-volume constraints, while anatomical plans were designed to meet standard 
constraints only.  See Appendix eII for the standard dose-volume constraints to major critical 
structures.  Functional image-guided planning was performed with lung dose-function objectives 
that incorporated regional percentile ventilation values [36], i.e., the image/voxel-based method 
rather than the structure-based method.  Beam angles were also optimized manually to avoid 155 
passing through highly-functional lung regions.  Plan adaptation was performed after both 16-20 
Gy and 30-34 Gy.  Unadapted plans were generated by simply copying the beams of the pre-RT 
plan onto the isocenters of the 16-20 Gy and 30-34 Gy planning CT images.  The Pinnacle3 
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treatment planning system, research version 9.7 (Philips Radiation Oncology Systems, 
Fitchburg, WI) was used in this study. 160 
 
Dose accumulation 
Dose accumulation was performed with the Demons DIR algorithm of the Pinnacle3 treatment 
planning system (research version 9.7), which was used to warp the mid-RT dose distributions 
as well as ventilation images to the pre-RT planning CT image.  It was presumed that the pre-165 
RT plan was delivered until the 16-20 Gy scan acquisition, followed by delivery of the 16-20 Gy 
plan until the 30-34 Gy scan acquisition, and finally delivery of the 30-34 Gy plan until the end of 
treatment.  To quantify the lung accumulated dose-function metrics with time-varying CT 
ventilation images before and during RT, a composite of dose-weighted ventilation was 
generated in this study.  The composite ventilation () in the voxel at location (, 	, 
) of the 170 
pre-RT planning CT image is defined by 
 ( ) ( )( ) ( )∑= t taccum
t
comp zyxV
zyxD
zyxD
zyxV ,,
,,
,,
,, ,  (1) 
where  is the time point (i.e., pre-RT, 16-20 Gy and 30-34 Gy), 	 is the dose of the pre-RT, 
16-20 Gy or 30-34 Gy plan,  is the accumulated dose, and  is the ventilation obtained 
from the pre-RT, 16-20 Gy or 30-34 Gy scan.   175 
 
Statistical analysis 
Characteristics of tumor regression were evaluated to examine whether the manually-contoured 
GTV on the 16-20 Gy and 30-34 Gy planning CT images were significantly smaller than that of 
the pre-RT planning CT (p<0.05) using the paired two-tailed t-test.  The correlation between 180 
GTV changes and ventilation changes in the tumor-affected lung halves was also investigated 
using the Pearson correlation coefficient.  Lung halves were segmented by dividing each of the 
right and left lungs into two parts at 4 cm below the carina, yielding four segments per patient.  
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Tumor-affected lung halves were defined as the segments that contained a tumor.  Moreover, 
the accumulated dose metrics of the functional plans were compared with those of the 185 
anatomical plans for each scenario separately (functional adapted vs. anatomical adapted; and 
functional unadapted vs. anatomical unadapted) to investigate whether the difference was 
statistically significant (p<0.05).  The paired two-tailed t-test was used for the lung dose-function 
metrics that were found to meet the criteria for normality based on skewness and kurtosis 
[44,45].  The two-tailed Wilcoxon rank-sum test was used for all the other metrics, most of which 190 
did not meet the criteria for normality..  The studied lung dose-function metrics include the 
functional mean lung dose (fMLD) (MLD weighted by regional ventilation) and f (percentage of 
ventilation receiving ≥ Gy). 
 
Results 195 
Tumor regression and regional ventilation changes 
Figure 1 shows pre- and mid-RT (after 34 Gy) CT ventilation images of a representative case 
(patient 1) overlaid on the respective planning CT images.  The GTV was 307 cm3 before RT, 
which was reduced by 48% to 158 cm3 after 34 Gy.  Tumor shrinkage resulted in increases of 
regional ventilation as shown in Figure 1.  The mean ventilation in the tumor-affected upper half 200 
of the left lung was 45% before RT, which was increased by 12% (relative increase) to 50%.  
For the 14 patients, the GTV was significantly reduced by 20% after 16-20 Gy (p=0.02) and by 
32% after 30-34 Gy (p<0.01) on average.  Figure 2 shows the relationship between GTV 
changes and ventilation changes in the tumor-affected lung halves measured with the two mid-
RT CT scans for all patients except for patient 8, for which ventilation changes could not be 205 
calculated due to complete collapse of the ipsilateral lung.  As GTV decreased, ventilation in the 
tumor-affected lung halves increased moderately but significantly (r = -0.53, p<0.01). 
 
Comparison of lung dose-function metrics 
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Figure 3 shows composite CT ventilation images (weighted by the functional adapted plan dose) 210 
overlaid on the planning CT images, accumulated dose distributions, and lung accumulated 
DFHs of the functional adapted and anatomical adapted plans for two representative patients.  
Patient 4 showed the largest reduction in the lung fV20 (5.6%) by functional plan adaptation 
compared to anatomical adaptation, while patient 6 showed the smallest reduction (1.4%).  
Changes in the GTV and ventilation changes were comparable between the two patients, e.g., 215 
GTV reductions after 32 Gy were 44% for patient 4 and 49% for patient 6, and ventilation 
increases in the tumor-affected lung halves were 8.2% for patient 4 and 7.7% for patient 6. 
 
Table 2 shows the average lung accumulated dose-function metrics of the functional adapted 
and unadapted plans in comparison with the anatomical adapted and unadapted plans for 14 220 
patients.  The mean dose, fV10, fV20 and fV30 were all found to be significantly lower in the 
functional adapted and unadapted plans than in the anatomical adapted and unadapted plans, 
respectively.  On average, functional planning significantly reduced the accumulated fMLD by 
5.0% (p<0.01) compared to anatomical planning in the adapted scenario, and by 3.6% (p=0.03) 
in the unadapted scenario.  Functional planning also resulted in significant reductions in the 225 
accumulated dose-volume metrics, e.g., MLD by 3.8% (13.3±3.7 Gy vs. 13.8±3.6 Gy, p<0.01) in 
the adapted scenario, and by 3.4% (14.0±3.7 Gy vs. 14.5±3.9 Gy, p<0.01) in the unadapted 
scenario. 
 
Comparison of dose-volume metrics of the CTV and other critical structures 230 
Table 3 shows the average accumulated dose-volume metrics of the CTV and other critical 
structures of the functional adapted and unadapted plans in comparison with the anatomical 
adapted and unadapted plans for 14 patients.  The accumulated D95% values of CTV, maximum 
dose to the spinal cord, mean dose to the esophagus, and V45 of the heart were all comparable 
between the functional and anatomical plans in both scenarios.  The accumulated D95% values 235 
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of CTV were 1.5-2 Gy lower in the adapted plans than in the unadapted plans, because the CTV 
was determined by adding the same margin at each time point assuming that the microscopic 
disease shrank synchronously with the GTV.  Note that the adapted and unadapted plans were 
not compared with each other for statistical significance in this study.  The concern on the risk of 
underdosing microscopic tumor extension is discussed below in the Discussion section.  240 
 
Discussion 
This study demonstrated significant reductions in the functional lung dose with CT ventilation 
image-guided RT planning compared to anatomical image-guided planning in both scenarios 
with and without plan adaptation for patients showing tumor regression and changes in regional 245 
ventilation during a course of treatment.  To our knowledge, this study is the first to quantify the 
dosimetric impact of changes in regional lung function during treatment as well as advantages 
of functional image-guided planning in two different scenarios with or without adaptation.  The 
results suggest that functional image-guided planning, whether adapted or unadapted, may 
provide clinical benefit, i.e., pulmonary toxicity reduction and quality of life improvement 250 
compared to anatomical image-guided planning.  We only performed dosimetric evaluations in 
the present study, which is not sufficient but serves as an important first step in building the 
evidence for functional image-guided RT.  Clinical trials will ultimately be necessary to 
determine its clinical significance.  Several clinical trials are currently underway to investigate 
the feasibility or efficacy of lung functional image-guided RT without adaptation, e.g., 255 
NCT02308709, 02528942, 02773238 and 02843568. 
 
There are several limitations to the present study.  First, treatment plans were created manually 
by an experienced dosimetrist, leading to a potential bias in favor of functional image-guided 
planning to reduce the lung dose more aggressively than anatomical image-guided planning.  260 
Functional image-guided planning resulted in significant reductions in not only the lung dose-
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function metrics (e.g., functional mean lung dose) but also the dose-volume metrics (e.g., mean 
lung dose) as mentioned above.  For future work, automated planning strategies [46-48] would 
allow for an unbiased, objective assessment.  A recent study has successfully developed a 
knowledge-based planning model for lung functional image-guided RT [48].  Second, there are 265 
technical limitation to CT ventilation imaging, including 4D CT image artifacts that deteriorate 
the accuracy and precision of CT ventilation [31,49].  Future developments of strategies to 
improve 4D CT would improve CT ventilation imaging as well. 
 
There are several challenges associated with adaptive RT strategies.  A potential pitfall of 270 
adaptive RT is the risk of underdosing microscopic tumor extension.  In this study, the CTV was 
determined by adding the same margin at each time point, assuming that the microscopic 
disease shrank synchronously with the GTV [21,22].  On the other hand, several other studies 
used DIR to propagate the CTV from the planning CT image before RT to the image during RT 
[22,50], considering that the microscopic disease might remain stationary [17].  Microscopic 275 
disease cannot be visualized with current imaging methods, leading to considerable 
uncertainties for individual patients.  We maintained consistency in target volume coverage 
between the paired plans in each scenario, allowing for fair comparisons.  Nevertheless, future 
developments of approaches to determine microscopic tumor extension are warranted to 
improve adaptive RT strategies.  Additionally, the increased workload associated with 280 
replanning that typically requires a quick turnaround time poses a challenge in the clinical 
implementation of adaptive RT.  Future developments of technologies to automate processes 
such as contouring, DIR and replanning may facilitate widespread implementation of adaptive 
RT.  On the other hand, CT ventilation imaging has a greater availability compared to other 
modalities, which offers a particular strength in the implementation of functional image-guided 285 
adaptive RT.  
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Conclusions 
This study demonstrated significant reductions in the accumulated dose to the functional lung 
with CT ventilation functional image-guided treatment planning compared to standard 290 
anatomical image-guided planning in two different scenarios with or without adaptation.  The 
findings of this study suggest the potential clinical benefit of functional image-guided plan 
adaptation for locally advanced lung cancer, i.e., pulmonary toxicity reduction and quality of life 
improvement.  Further studies, including clinical trials, are needed to determine its clinical 
significance. 295 
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Figure legends 
Figure 1. Pre- and mid-RT (after 34 Gy) CT ventilation images of a representative case (patient 425 
1) overlaid on the respective planning CT images, which showed a 48% reduction in the tumor 
volume (red arrows) and a 12% increase in ventilation in the tumor-affected upper half of the left 
lung. 
 
Figure 2. Gross tumor volume (GTV) changes vs. ventilation changes in the tumor-affected lung 430 
halves measured with two mid-RT CT scans (after 16-20 and 30-34 Gy) for all patients except 
for patient 8, for which ventilation changes could not be calculated due to complete collapse of 
the ipsilateral lung. 
 
Figure 3. Composite CT ventilation images (weighted by the functional image-guided adapted 435 
plan dose), accumulated dose distributions, and lung accumulated dose-function histograms of 
the functional image-guided adapted and anatomical image-guided adapted plans for patient 4, 
showing the largest reduction in the lung functional V20 (5.6%) by functional image-guided 
adaptation.  10-30 Gy regions are pushed away from highly-functional lung regions (red arrows).  
Patient 6 showed the smallest reduction (1.4%).  Shaded red: clinical target volume (CTV). 440 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Table 1. Patient characteristics 
Parameter Data 
Age (y)  
 Median 74 
 Range 57-84 
Gender  
 Male 6 (42.9) 
 Female 8 (57.1) 
Stage  
 IIIA 8 (57.1) 
 IIIB 6 (42.9) 
Tumor location  
 RUL 6 (42.9) 
 RLL 3 (21.4) 
 LUL 5 (35.7) 
PTV (cm3)  
 Median 472 
 Range 255-750 
Lung volume (cm3)  
 Median 2751 
 Range 2164-6287 
Dose delivered prior to the 1st CT during RT (Gy)  
 Median 18 
 Range 16-20 
Dose delivered prior to the 2nd CT during RT (Gy)  
 Median 32 
 Range 30-34 
Abbreviations: RUL = right upper lobe; RLL; right lower lobe; LUL = left upper lobe; PTV = 
planning target volume, CT = computed tomography, RT = radiotherapy. 
Data presented as the value of parameter or the number of patients with percentages in 
parentheses. 5 
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Table 2. Average lung accumulated dose-function metrics of the CT ventilation functional image-guided adapted and unadapted 
plans in comparison with the anatomical adapted and unadapted plans for 14 patients 
 
Planning scheme 
Mean (SD) 
(Gy) 
fV10 (SD) 
(%) 
fV20 (SD) 
(%) 
fV30 (SD) 
(%) 
Functional w/ adaptation 13.1 (3.9) 41.5 (14.3) 21.3 (8.6) 12.7 (5.7) 
Anatomical w/ adaptation 13.8 (4.3) 44.3 (14.4) 23.8 (10.1) 13.8 (6.6) 
 P (vs. functional w/ adaptation) <0.01 0.02 <0.01 <0.01 
Functional w/o adaptation 13.9 (3.8) 43.6 (14.8) 23.1 (8.0) 13.9 (5.8) 
Anatomical w/o adaptation 14.4 (4.2) 45.8 (15.0) 25.7 (10.2) 14.9 (6.3) 
 P (vs. functional w/o adaptation) 0.03 0.03 <0.01 <0.01 
Abbreviation: SD = standard deviation; fVx = percentage lung function receiving ≥x Gy. 
10 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
Table 3. Average accumulated dose-volume metrics of the CTV and other critical structures of the CT ventilation functional image-
guided adapted and unadapted plans in comparison with the anatomical adapted and unadapted plans for 14 patients 
 
Planning scheme 
CTV D95% (SD)  
(Gy) 
Spinal cord max (SD) 
(Gy) 
Esophagus mean (SD)  
(Gy) 
Heart V45 (SD) 
(%) 
Functional w/ adaptation 58.9 (3.5) 36.7 (8.3) 24.6 (7.5) 3.2 (2.9) 
Anatomical w/ adaptation 58.5 (3.6) 34.2 (8.9) 24.3 (7.3) 3.1 (2.8) 
 P (vs. functional w/ adaptation) 0.60 0.26 0.91 0.99 
Functional w/o adaptation 60.6 (2.6) 38.3 (10.1) 26.3 (8.1) 3.4 (3.5) 
Anatomical w/o adaptation 60.4 (2.6) 37.6 (9.7) 26.3 (8.0) 3.2 (3.0) 
 P (vs. functional w/o adaptation) 0.60 0.66 0.98 0.82 
Abbreviation: CTV = clinical target volume; SD = standard deviation; D95% = dose to 95% of the volume; Vx = percentage volume 
receiving ≥x Gy. 
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Summary: This paper reports on the first investigation to quantify the dosimetric advantages of 
computed tomography (CT) ventilation functional image-guided treatment planning for lung 
cancer in two different scenarios with or without plan adaptation.  The results showed significant 
reductions in the accumulated dose to the functional lung with functional image-guided planning 
compared to anatomical image-guided planning in both scenarios for patients showing tumor 5 
regression and changes in regional ventilation during treatment. 
 
